144186-34-5

Basic information

• Product Name: (2R,5R)-1,6-Diphenyl-2,5-hexanediamine
• Synonyms: (2R,5R)-1,6-Diphenyl-2,5-hexanediamine;1,6-diphenylhexane-2,5-diamine
• CAS NO: 144186-34-5
• Molecular Formula: C₁₈H₂₄N₂
• Molecular Weight: 268.39656
• Mol File: 144186-34-5.mol

Chemical Properties

• Boiling Point: 439.9±45.0 °C(Predicted)
• Appearance: /
• Density: 1.044±0.06 g/cm3(Predicted)
• PKA: 10.95±0.35(Predicted)
• CAS DataBase Reference: (2R,5R)-1,6-Diphenyl-2,5-hexanediamine(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,5R)-1,6-Diphenyl-2,5-hexanediamine(144186-34-5)
• EPA Substance Registry System: (2R,5R)-1,6-Diphenyl-2,5-hexanediamine(144186-34-5)

Safety Data

• Hazardous Substances Data: 144186-34-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(2R,5R)-1,6-Diphenyl-2,5-hexanediamine is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the formation of complex organic molecules. Its specific stereochemistry allows for targeted reactions and the creation of compounds with desired therapeutic properties.
Used in Organic Material Synthesis:
In the field of organic material synthesis, (2R,5R)-1,6-Diphenyl-2,5-hexanediamine is used as a building block for creating a range of organic compounds. Its unique structure and reactivity enable the development of new materials with specific properties for various applications.
Used in Polymer Production:
(2R,5R)-1,6-Diphenyl-2,5-hexanediamine is used as a monomer or a component in the production of polymers. Its incorporation into polymer chains can influence the polymer's properties, such as strength, flexibility, and chemical resistance, making it suitable for specific industrial applications.
Used in Industrial Material Production:
(2R,5R)-1,6-Diphenyl-2,5-hexanediamine is also utilized in the production of various industrial materials, where its unique structure and properties can enhance the performance of the final product. Its applications in this industry can range from improving material characteristics to enabling new functionalities.

Upstream product

• 168846-62-6 (2S,5S)-2,5-bis-<(1,1-dimethylethoxy)carbonylamino>-1,6-diphenylhex-3-ene 
• 144163-56-4 C₃₄H₃₄N₂O₄ 
• 1004316-59-9 C₃₄H₃₄N₂O₄ 
• 1004316-39-5 C₃₅H₄₄N₂O₄ 
• 1004318-16-4 C₁₈H₂₂N₂ 
• 1448312-65-9 1,6-diphenyl-5(S)-tert-butoxycarbonylamino-3(S)-hydroxy-2(S)-phenylmethoxy-carbonylaminohexane 
• 144163-85-9 (2S,3S,5S)-2-amino-3-hydroxy-5-(t-butyloxycarbonylamino)-1,6-diphenylhexane 
• 1448312-72-8 3(S)-toluene-4-sulfonic acid 1,6-diphenyl-5(S)-tert-butoxycarbonylamino-2(S)-phenylmethoxycarbonylaminohexane, ester 
• 1448312-73-9 3(S)-toluene-4-sulfonic acid 1,6-diphenyl-5(S)-amino-2(S)-phenylmethoxycarbonylaminohexane, ester 
• 1383570-59-9 tert-butyl [(2R,5R)-5-amino-1,6-diphenylhexan-2-yl]carbamate 

Downstream Products

• 1004316-18-0 C₂₃H₂₇N₃O₂S 
• 1004318-11-9 C₃₂H₄₅N₅O₂S 
• 1004318-10-8 C₄₆H₆₆N₈O₄S₂ 

Relevant articles and documents

For the synthesis of anti-aids agent potentiators cobicistat intermediates

The invention relates to a method for synthesizing a novel midbody compound I for synthesizing an anti-AIDS medicine reinforcing agent cobicistat and further discloses a method for synthesizing (2R,5R)-1,6-diphenyl-2,5-hexamethylendiamine by using the com

METHODS AND INTERMEDIATES FOR PREPARING PHARMACEUTICAL AGENTS

Methods and intermediates useful for preparing a compound of formula I and salts thereof.

METHODS AND INTERMEDIATES FOR PREPARING PHARMACEUTICAL AGENTS

The invention provides methods and intermediates that are useful for preparing a compound of formula I: and salts thereof.

A novel and efficient synthesis of chiral C2-symmetric 1,4-diamines

A novel and efficient method for synthesis of (R,R)- and (S,S)-C2-symmetric 1,4-diamines was established. The key steps are a combination of Pinacol Coupling and Corey-Winter olefination.

MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS

The present application provides for a compound of Formula I, or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods and include the administration of such compounds with at least one additional therapeutic agent.